These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24130405)

  • 1. Clinical significance of benign endometrial cells found in papanicolaou tests of Turkish women aged 40 years and older.
    Kir G; Gocmen A; Cetiner H; Topal CS; Yilmaz MS; Karabulut MH
    J Cytol; 2013 Jul; 30(3):156-8. PubMed ID: 24130405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers.
    Aslan DL; Crapanzano JP; Harshan M; Erroll M; Vakil B; Pirog EC
    Gynecol Oncol; 2007 Oct; 107(1):86-93. PubMed ID: 17604086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of finding benign endometrial cells in women 40-45 versus 46 years or older on Papanicolaou tests and histologic follow-up.
    Colletti SM; Tranesh GA; Nassar A
    Cytojournal; 2017; 14():22. PubMed ID: 29021811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of foamy histiocytes in cervical smears from postmenopausal women.
    Kir G; Yilmaz MS; Çetiner H; Gocmen A; Alptekin F
    Acta Cytol; 2014; 58(1):42-6. PubMed ID: 24296692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of Endometrial Cells in Pap Smear of Women Aged 40 Years and Older.
    Keleş E; Öztürk UK; Alinca CM; Akiş S; Kabaca C; Çetiner H
    Turk Patoloji Derg; 2022; 38(3):235-239. PubMed ID: 35147975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of benign endometrial cells in postmenopausal women.
    Ashfaq R; Sharma S; Dulley T; Saboorian MH; Siddiqui MT; Warner C
    Diagn Cytopathol; 2001 Oct; 25(4):235-8. PubMed ID: 11599107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative Predictive Value and Significance of Benign-Appearing Endometrial Cells in Papanicolaou Tests.
    Yu J; Onisko A; Austin RM
    Am J Clin Pathol; 2017 Sep; 148(3):274-279. PubMed ID: 28821196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal-Appearing Endometrial Cells in Pap Tests of Women Aged Forty Years or Older and Cytohistological Correlates.
    Izadi-Mood N; Sarmadi S; Sanii S; Sadidi H
    Acta Cytol; 2015; 59(2):175-9. PubMed ID: 25924690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Significance of Endometrial Cells Detected on Pap Testing: The Impact of Revisions to the 3rd Edition of the Bethesda System for Reporting Cervical Cytology.
    Morikawa LH; Tauchi-Nishi PS
    Ann Clin Lab Sci; 2017 May; 47(3):298-305. PubMed ID: 28667030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Papanicolaou smears, benign appearing endometrial cells bear no significance in predicting uterine endometrial adenocarcinomas.
    Moatamed NA; Le LT; Levin MR; Govind R; Apple SK
    Diagn Cytopathol; 2013 Apr; 41(4):335-41. PubMed ID: 22102567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women.
    Chang A; Sandweiss L; Bose S
    Gynecol Oncol; 2001 Jan; 80(1):37-43. PubMed ID: 11136567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of endometrial cells in cervical cytology.
    Yu EJ; Park NH; Song YS; Lee YK
    J Obstet Gynaecol; 2016 Oct; 36(7):966-969. PubMed ID: 27560859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the Bethesda System 2014 on endometrial cell reporting and follow-up endometrial biopsies in women 45 years of age and over.
    Moyer AB; El-Zaatari ZM; Thrall MJ
    J Am Soc Cytopathol; 2018; 7(4):201-204. PubMed ID: 31043277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting of Benign Endometrial Cells in Papanicolaou Tests.
    Hernandez A; Schatz-Siemers N; Zhou F; Brandler TC; Negron R; Modi L; Elgert PA; Simsir A
    Am J Clin Pathol; 2020 Aug; 154(3):381-386. PubMed ID: 32405650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Age Cutoff Criterion for Reporting Benign-Appearing Endometrial Cells in Routine Pap Tests: An 8-Year Retrospective Review.
    Grada Z; Paquette C; Eklund CM; Zhang C; Sung CJ; Steinhoff M; Quddus MR
    Acta Cytol; 2017; 61(3):194-198. PubMed ID: 28486237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial cells in pap smears of postmenopausal women: cytohistologic correlation.
    Cai N; Spitzer M; Wasserman PG
    J Low Genit Tract Dis; 2003 Oct; 7(4):250-3. PubMed ID: 17051079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System.
    Bean SM; Connolly K; Roberson J; Eltoum I; Chhieng DC
    Cancer; 2006 Feb; 108(1):39-44. PubMed ID: 16329117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
    Nassar A; Fleisher SR; Nasuti JF
    Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of benign endometrial cells in papanicolaou tests from women aged >or=40 years.
    Thrall MJ; Kjeldahl KS; Savik K; Gulbahce HE; Pambuccian SE
    Cancer; 2005 Aug; 105(4):207-16. PubMed ID: 15900572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy.
    Mount SL; Wegner EK; Eltabbakh GH; Olmstead JI; Drejet AE
    Obstet Gynecol; 2002 Sep; 100(3):445-50. PubMed ID: 12220762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.